Comparison between Chemplast Sanmar IPO and Vijaya Diagnostic Centre IPO.
Chemplast Sanmar IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Vijaya Diagnostic Centre IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Chemplast Sanmar IPO is up to ₹3,850.00 Cr whereas the issue size of the Vijaya Diagnostic Centre IPO is up to ₹1,894.43 Cr. The final issue price of Chemplast Sanmar IPO is ₹541.00 per share and of Vijaya Diagnostic Centre IPO is ₹531.00 per share.
| Chemplast Sanmar IPO | Vijaya Diagnostic Centre IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹1 per share |
| Issue Price (Lower) | ₹530.00 per share | ₹522.00 per share |
| Issue Price (Upper) | ₹541.00 per share | ₹531.00 per share |
| Issue Price (Final) | ₹541.00 per share | ₹531.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹52.00 per share | |
| Market Lot Size | 27 shares | 28 shares |
| Fresh Issue Size | 2,40,29,574 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹1,300.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 4,71,34,935 shares | 3,56,88,064 shares |
| OFS Issue Size (Amount) | up to ₹2,550.00 Cr | up to ₹1,894.43 Cr |
| Issue Size Total | 7,11,64,509 shares | 3,56,88,064 shares |
| Issue Size Total (Amount) | up to ₹3,850.00 Cr | up to ₹1,894.43 Cr |
Chemplast Sanmar IPO opens on Aug 10, 2021, while Vijaya Diagnostic Centre IPO opens on Sep 01, 2021. The closing date of Chemplast Sanmar IPO and Vijaya Diagnostic Centre IPO is Aug 12, 2021, and Sep 03, 2021, respectively.
| Chemplast Sanmar IPO | Vijaya Diagnostic Centre IPO | |
|---|---|---|
| Anchor Bid Date | Aug 09, 2021 | Aug 31, 2021 |
| Issue Open | Aug 10, 2021 | Sep 01, 2021 |
| Issue Close | Aug 12, 2021 | Sep 03, 2021 |
| Basis Of Allotment (Tentative) | Aug 18, 2021 | Sep 08, 2021 |
| Initiation of Refunds (Tentative) | Aug 20, 2021 | Sep 09, 2021 |
| Credit of Share (Tentative) | Aug 23, 2021 | Sep 13, 2021 |
| Listing date (Tentative) | Aug 24, 2021 | Sep 14, 2021 |
| Anchor Lockin End date 1 | Sep 17, 2021 | Oct 08, 2021 |
| Anchor Lockin End date 2 | Nov 16, 2021 | Dec 07, 2021 |
Chemplast Sanmar IPO P/E ratio is , as compared to Vijaya Diagnostic Centre IPO P/E ratio of .
| Chemplast Sanmar IPO | Vijaya Diagnostic Centre IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 59.78 | ||||
| Promoter Shareholding (Post-Issue) | 54.99 | 54.78 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹8553.73 Cr. | ₹5414.39 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Chemplast Sanmar IPO Retail Individual Investors (RII) are offered 71,16,450 shares while in Vijaya Diagnostic Centre IPO retail investors are offered 71,16,450 shares. Qualified Institutional Buyers (QIB) are offered 2,13,49,354 shares in Chemplast Sanmar IPO and 71,07,613 shares in Vijaya Diagnostic Centre IPO.
| Chemplast Sanmar IPO | Vijaya Diagnostic Centre IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,20,24,029 shares | 1,06,61,418 shares |
| Market Maker Reservation | ||
| QIB | 2,13,49,354 shares | 71,07,613 shares |
| NII | 1,06,74,676 shares | 53,30,710 shares |
| RII | 71,16,450 shares | 1,24,38,323 shares |
| Employee | 1,50,000 shares | |
| Others | ||
| Total | 7,11,64,509 shares | 3,56,88,064 shares |
Chemplast Sanmar IPO subscribed 2.17x in total, whereas Vijaya Diagnostic Centre IPO subscribed 4.54x.
| Chemplast Sanmar IPO | Vijaya Diagnostic Centre IPO | |
|---|---|---|
| QIB (times) | 2.70x | 13.07x |
| NII (times) | 1.03x | 1.32x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.29x | 1.09x |
| Employee (times) | 0.98x | |
| Other (times) | ||
| Total (times) | 2.17x | 4.54x |
